iBio (IBIO) Return on Capital Employed [ROCE] (2011 - 2026)
iBio (IBIO) posted Return on Capital Employed [ROCE] of -43.53% for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 80.17 percentage points from -123.70% a year earlier but down 1.32 percentage points from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), iBio's Return on Capital Employed [ROCE] came in at -71.13%, up 22.56 percentage points from FY2025.
- Annual Return on Capital Employed [ROCE] shows a five-year change of -43.83 percentage points (FY2021 to FY2026).
- In prior fiscal years, iBio's Return on Capital Employed [ROCE] was -93.70% in FY2025 (-40.26 pp), -53.43% in FY2024 (+7.45 pp), -60.88% in FY2023 (-28.86 pp) and -32.02% in FY2022 (-4.71 pp).
- Quarterly Return on Capital Employed [ROCE] has run from a low of -145.02% in fiscal Q2 2024 to a high of -21.43% in fiscal Q1 2022 over five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] has increased in each of the last four quarters, with an average year-over-year change of +29.89 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was fiscal Q4 2024, with a gain of 95.12 percentage points; the weakest was fiscal Q3 2023, with a drop of 109.45 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior fiscal quarters was -42.21% (Q3 2026), -43.64% (Q2 2026) and -54.35% (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | iBio | 116.55 Mn | 116.55 Mn | - | -43.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -43.53% |
| Mar 31, 2026 | -42.21% |
| Dec 31, 2025 | -43.64% |
| Sep 30, 2025 | -54.35% |
| Jun 30, 2025 | -123.70% |
| Mar 31, 2025 | -112.06% |
| Dec 31, 2024 | -84.57% |
| Sep 30, 2024 | -67.53% |
| Jun 30, 2024 | -46.72% |
| Mar 31, 2024 | -88.04% |
| Dec 31, 2023 | -145.02% |
| Sep 30, 2023 | -143.10% |
| Jun 30, 2023 | -141.84% |
| Mar 31, 2023 | -134.91% |
| Dec 31, 2022 | -87.73% |
| Sep 30, 2022 | -53.70% |
| Jun 30, 2022 | -38.59% |
| Mar 31, 2022 | -25.47% |
| Dec 31, 2021 | -22.96% |
| Sep 30, 2021 | -21.43% |
API Access
iBio Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();